EUROPÄISCHE LEITLINIEN & KONSENSUSPAPIERE
Hier finden Sie die bereits bestehenden europäischen Leitlinien und Konsensuspapiere zu folgenden Erkrankungsgruppen:
Cystische Fibrose (CF)
- 2023. ECFS standards of care for CTFR variant-specific therapy (including modulators) for people with cystic fibrosis.
- 2022. Standards of care on CFTR-related disorders: Updated diagnostic criteria.
- 2020. Optimizing Pharmaceutical Care in Cystic Fibrosis. ECFS Book
- 2018. ECFS best practice guidelines: the 2018 revision
- 2018. The Early Cystic Fibrosis Years. ECFS Book 2018.
- 2015. Living Longer with Cystic Fibrosis. ECFS Book.
PULMONALE HYPERTONIE (PH)
- 2023. European Society of Cardiology Quality Indicators for the care and outcomes of adults with pulmonary arterial hypertension.
- 2022. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
- 2021. ERS Statement on Chronic Thromboembolic Pulmonary Hypertension.
- 2020. Protocole National de Diagnostic et de Soins (PNDS) Hypertension Artérielle Pulmonaire (in French)
- 2019. ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension
- 2019. ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society
- 2015. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
INTERSTITIELLE LUNGENERKRANKUNG (ILD)
- 2022. ERS Guidelines on transbronchial lung cryobiopsy in the diagnosis of interstitial lung diseases
- 2022. Idiopathic pulmonary fibrosis (an Update) and progressive pulmonary fibrosis in adults.
- 2021. ERS clinical practice guidelines on treatment of sarcoidosis
- 2020. Sitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Diagnosis of Hypersen
- 2020. Diagnosis and Detection of Sarcoidosis: An Official American Thoracic Society Clinical Practice Guideline
- 2018. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
- 2016. Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management
- 2015. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis.
ALPHA 1- ANTITRYPSINMANGEL
PRIMÄRE ZILIÄRE DYSKINESE (PZD)
- 2021. Current and future treatments in primary ciliary dyskinesia
- 2020. International consensus guideline for reporting transmission electron microscopy results in the diagnosis of primary ciliary dyskinesia (BEAT PCD TEM Criteria)
- 2016. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia.
- 2010. Factors influencing age at diagnosis of primary ciliary dyskinesia in European children.
- 2009. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children.
NON-CF-BRONCHIEKTASEN
- 2020. ERS Guidelines for the management of children and adolescents with bronchiectasis.
- 2019. Recommendations for travelling with bronchiectasis: a joint ELF/EMBARC/ERN-Lung collaboration.
- 2019. British Thoracic Society Guideline for bronchiectasis in adults.
- 2018. Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network.
- 2018. Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults.
- 2017. European Respiratory Society guidelines for the management of adult bronchiectasis.
- 2017. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research.
- 2016. Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration.
ANDERE SELTENE LUNGENERKRANKUNGEN